• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺肿瘤的起源细胞。

Cells of origin of pancreatic neoplasms.

作者信息

Yamaguchi Junpei, Yokoyama Yukihiro, Kokuryo Toshio, Ebata Tomoki, Nagino Masato

机构信息

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.

出版信息

Surg Today. 2018 Jan;48(1):9-17. doi: 10.1007/s00595-017-1501-2. Epub 2017 Mar 4.

DOI:10.1007/s00595-017-1501-2
PMID:28260136
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignant disease associated with poor prognosis, despite recent medical advances. It is of great importance to understand the initial events and cells of origin of pancreatic cancer to prevent the development and progression of PDAC. There are three distinct precursor lesions that develop into PDAC: pancreatic intraepithelial neoplasms (PanINs), intraductal papillary mucinous neoplasms (IPMNs), and mucinous cystic neoplasms (MCNs). Studies on genetically engineered mouse models have revealed that the initiation and development of these lesions largely depend on genetic alterations. These lesions originate from different populations in the pancreas. PanIN development seems to be the result of the transdifferentiation of acinar cells, whereas IPMNs most likely arise from the progenitor niche of the pancreatic ductal epithelium. Pancreatic carcinogenesis is dependent on various events, including gene alterations, environmental insults, and cell types. However, further studies are needed to fully understand the initial processes of pancreatic cancer.

摘要

尽管近年来医学取得了进步,但胰腺导管腺癌(PDAC)仍是一种预后不良的致命恶性疾病。了解胰腺癌的起始事件和起源细胞对于预防PDAC的发生和发展至关重要。有三种不同的前驱病变会发展为PDAC:胰腺上皮内瘤变(PanINs)、导管内乳头状黏液性肿瘤(IPMNs)和黏液性囊性肿瘤(MCNs)。对基因工程小鼠模型的研究表明,这些病变的起始和发展很大程度上依赖于基因改变。这些病变起源于胰腺中的不同细胞群。PanIN的发展似乎是腺泡细胞转分化的结果,而IPMNs很可能起源于胰腺导管上皮的祖细胞龛。胰腺癌的发生依赖于各种事件,包括基因改变、环境损伤和细胞类型。然而,需要进一步研究以充分了解胰腺癌的初始过程。

相似文献

1
Cells of origin of pancreatic neoplasms.胰腺肿瘤的起源细胞。
Surg Today. 2018 Jan;48(1):9-17. doi: 10.1007/s00595-017-1501-2. Epub 2017 Mar 4.
2
Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.丝氨酸蛋白酶抑制剂Kazal 1型和表皮生长因子受体在胰腺导管腺癌、导管内乳头状黏液性肿瘤及胰腺上皮内瘤变中均有表达。
J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6.
3
[Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].胰腺上皮内瘤变(PanIN)和导管内乳头状黏液性肿瘤(IPMN)作为胰腺癌的前驱病变
Med Klin (Munich). 2007 Feb 15;102(2):127-35. doi: 10.1007/s00063-007-1013-8.
4
Current understanding of precursors to pancreatic cancer.胰腺癌前体的当前认识。
J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. doi: 10.1007/s00534-006-1165-6. Epub 2007 May 29.
5
Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.导管内乳头状黏液性肿瘤及导管内乳头状黏液性肿瘤衍生的胰腺导管腺癌的分子机制
J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):519-23. doi: 10.1002/jhbp.246. Epub 2015 Apr 21.
6
[New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].[胰腺癌起源的新见解。非典型扁平病变在胰腺癌发生中的作用]
Pathologe. 2012 Nov;33 Suppl 2:189-93. doi: 10.1007/s00292-012-1673-x.
7
Acvr1b Loss Increases Formation of Pancreatic Precancerous Lesions From Acinar and Ductal Cells of Origin.ACVR1B 缺失增加源自胰腺腺泡和导管细胞的胰腺癌前病变的形成。
Cell Mol Gastroenterol Hepatol. 2024;18(5):101387. doi: 10.1016/j.jcmgh.2024.101387. Epub 2024 Aug 5.
8
Where and when does pancreatic carcinoma start?胰腺癌始于何处,始于何时?
Med Klin (Munich). 2004 Apr 15;99(4):191-5. doi: 10.1007/s00063-004-1028-3.
9
Pancreatic Acinar-to-Ductal Metaplasia and Pancreatic Cancer.胰腺腺泡-导管化生与胰腺癌
Methods Mol Biol. 2019;1882:299-308. doi: 10.1007/978-1-4939-8879-2_26.
10
Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.胰腺上皮内瘤变、胰管内乳头状黏液性肿瘤和胰腺浸润性导管癌之间 ezrin 和磷酸化 ezrin 表达谱的差异。
Hum Pathol. 2013 Aug;44(8):1487-98. doi: 10.1016/j.humpath.2012.12.001. Epub 2013 Mar 1.

引用本文的文献

1
Proteomics in pancreatic cancer.胰腺癌中的蛋白质组学
Biomark Res. 2025 Jul 6;13(1):93. doi: 10.1186/s40364-025-00805-y.
2
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer.自我扩增的NRF2-EZH2表观遗传环将KRAS启动的祖细胞转化为侵袭性胰腺癌。
Nat Cancer. 2025 Jun 30. doi: 10.1038/s43018-025-01003-3.
3
Comprehensive insights into pancreatic cancer treatment approaches and cutting-edge nanocarrier solutions: from pathology to nanomedicine.胰腺癌治疗方法与前沿纳米载体解决方案的全面见解:从病理学至纳米医学。

本文引用的文献

1
Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.术前放化疗不会影响胰腺导管腺癌患者辅助化疗的可行性。
Surg Today. 2017 Feb;47(2):218-226. doi: 10.1007/s00595-016-1405-6. Epub 2016 Sep 1.
2
Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.胰腺导管腺体重三叶因子2缺失促进小鼠导管内乳头状黏液性肿瘤的形成。
Gastroenterology. 2016 Dec;151(6):1232-1244.e10. doi: 10.1053/j.gastro.2016.07.045. Epub 2016 Aug 12.
3
Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04094-y.
4
Methylation of is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.的甲基化是胰腺癌中ATR/CHK1抑制剂的合成致死标志物。 (你提供的原文中“Methylation of ”后面似乎缺少具体内容)
J Transl Int Med. 2024 Jul 27;12(3):274-287. doi: 10.2478/jtim-2023-0128. eCollection 2024 Jun.
5
Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis.综合 DNA 甲基化分析表明,胰腺上皮内瘤变病变来源于腺泡,并在表观遗传学上为癌变做好了准备。
Cancer Res. 2023 Jun 2;83(11):1905-1916. doi: 10.1158/0008-5472.CAN-22-4052.
6
Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm.临床和分子特征与胰腺囊性肿瘤评估。
Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188851. doi: 10.1016/j.bbcan.2022.188851. Epub 2022 Dec 16.
7
Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes.胰腺导管腺癌起源的细胞类型:对预后和临床结果的影响
Visc Med. 2022 Feb;38(1):4-10. doi: 10.1159/000520946. Epub 2021 Dec 27.
8
Cephalic undifferentiated carcinoma with osteoclast-like giant cells arising from the main pancreatic duct: case report and literature review.起源于主胰管的伴有破骨细胞样巨细胞的头状未分化癌:病例报告及文献综述
Arch Clin Cases. 2021 Oct 27;6(1):6-21. doi: 10.22551/2019.22.0601.10148. eCollection 2019.
9
Stem/progenitor cells in normal physiology and disease of the pancreas.胰腺正常生理和疾病中的干细胞/祖细胞。
Mol Cell Endocrinol. 2021 Dec 1;538:111459. doi: 10.1016/j.mce.2021.111459. Epub 2021 Sep 20.
10
Possibility for Transcriptional Targeting of Cancer-Associated Fibroblasts-Limitations and Opportunities.癌症相关成纤维细胞转录靶向的可能性:限制与机遇。
Int J Mol Sci. 2021 Mar 24;22(7):3298. doi: 10.3390/ijms22073298.
双皮质素样激酶1(Dclk1)定义了促进损伤诱导的再生和肿瘤发生的静止胰腺祖细胞。
Cell Stem Cell. 2016 Apr 7;18(4):441-55. doi: 10.1016/j.stem.2016.03.016.
4
Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style.成体细胞在体内的可塑性:去分化和转分化再度流行。
Nat Rev Mol Cell Biol. 2016 Jul;17(7):413-25. doi: 10.1038/nrm.2016.24. Epub 2016 Mar 16.
5
Stem cells versus plasticity in liver and pancreas regeneration.肝和胰腺再生中的干细胞与可塑性。
Nat Cell Biol. 2016 Mar;18(3):238-45. doi: 10.1038/ncb3309.
6
Regulation of Cellular Identity in Cancer.癌症中细胞身份的调控。
Dev Cell. 2015 Dec 21;35(6):674-84. doi: 10.1016/j.devcel.2015.12.001.
7
Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin.发育途径直接从细胞起源引发胰腺癌。
Stem Cells Int. 2016;2016:9298535. doi: 10.1155/2016/9298535. Epub 2015 Nov 22.
8
p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells.p53 突变与致癌性 Kras 协同作用,促进胰腺导管细胞腺癌的发生。
Oncogene. 2016 Aug 11;35(32):4282-8. doi: 10.1038/onc.2015.441. Epub 2015 Nov 23.
9
GEMMs as preclinical models for testing pancreatic cancer therapies.基因工程小鼠模型作为测试胰腺癌治疗方法的临床前模型。
Dis Model Mech. 2015 Oct 1;8(10):1185-200. doi: 10.1242/dmm.021055.
10
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.激活素受体1B型缺失加速KRAS激活小鼠导管内乳头状黏液性肿瘤的发展。
Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25.